Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Gui

Showing results (171-180 of 251) with videos related to

Pageof 26
Sort By:
Annals of Hematology|November 19, 2016
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specifiedFei Qi, Mei Dong, Xiaohui He, et al.
Cytokine|April 6, 2013
hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathwayZhen Ke, Dingfang Liang, Qingyu Zeng, et al.
Oncotarget|April 15, 2017
Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal typeWumin Dai, Bo Jia, Jianliang Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Clinical features and prognostic analysis of mantle cell lymphoma patients]Ping Zhou, Yuankai Shi, Xiaohui He, et al.
Materials (Basel, Switzerland)|February 25, 2022
A U-Shaped Dual-Frequency-Reconfigurable Monopole Antenna Based on Liquid MetalPeng Qin, Qian-Yu Wang, Jun-Heng Fu, et al.
Oncotarget|October 18, 2016
Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern eraQin Wang, Yan Qin, Shengyu Zhou, et al.
Targeted Oncology|April 21, 2024
Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment OutcomesZucheng Xie, Yan Qin, Xinrui Chen, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy]Lin Gui, Yuankai Shi, Xiaohui He, et al.
Cellular and Molecular Life Sciences : CMLS|June 30, 2015
Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cellsQingyu Zeng, Hai Zhang, Jiamin Qin, et al.
Annals of Hematology|July 12, 2017
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal typeYu Huang, Jianliang Yang, Peng Liu, et al.
Pageof 26

Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
Annals of Hematology|November 19, 2016
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specifiedFei Qi, Mei Dong, Xiaohui He, et al.
Cytokine|April 6, 2013
hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathwayZhen Ke, Dingfang Liang, Qingyu Zeng, et al.
Oncotarget|April 15, 2017
Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal typeWumin Dai, Bo Jia, Jianliang Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Clinical features and prognostic analysis of mantle cell lymphoma patients]Ping Zhou, Yuankai Shi, Xiaohui He, et al.
Materials (Basel, Switzerland)|February 25, 2022
A U-Shaped Dual-Frequency-Reconfigurable Monopole Antenna Based on Liquid MetalPeng Qin, Qian-Yu Wang, Jun-Heng Fu, et al.
Oncotarget|October 18, 2016
Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern eraQin Wang, Yan Qin, Shengyu Zhou, et al.
Targeted Oncology|April 21, 2024
Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment OutcomesZucheng Xie, Yan Qin, Xinrui Chen, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy]Lin Gui, Yuankai Shi, Xiaohui He, et al.
Cellular and Molecular Life Sciences : CMLS|June 30, 2015
Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cellsQingyu Zeng, Hai Zhang, Jiamin Qin, et al.
Annals of Hematology|July 12, 2017
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal typeYu Huang, Jianliang Yang, Peng Liu, et al.
Pageof 26